Application 200998
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 200MG | No | No |
| 002 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 400MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-4147 | Meprobamate | Meprobamate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4148 | Meprobamate | Meprobamate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 52549-4147 | Meprobamate | Meprobamate | Taro Pharmaceutical Industries Ltd. | ANDA | Current |
| 52549-4148 | Meprobamate | Meprobamate | Taro Pharmaceutical Industries Ltd. | ANDA | Current |